The FDA will now require drug manufacturers to add clear information about the risk of addiction, misuse, and overdose on opioid prescription labels.

Identifying the drug can be difficult, given that many overdose toxicology tests don’t include nitazenes, the Journal reports ...

Makers of the controversial herbal supplements, while amenable to regulations, have been plagued by infighting.

The AHA released a new toolkit to improve continuity of care for patients with opioid and stimulant use disorders. Developed with support from the Centers for Disease Control and Prevention and in ...

The number of deaths due to toxic drugs fell to below 150 people per month for May and June in British Columbia, a downward ...

"The air quality is officially dangerous in Chicago," says Brian Urbaszewski, director of environmental health programs at ...